These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11216915)

  • 1. CYP19 gene polymorphism in endometrial cancer patients.
    Berstein LM; Imyanitov EN; Suspitsin EN; Grigoriev MY; Sokolov EP; Togo A; Hanson KP; Poroshina TE; Vasiljev DA; Kovalevskij AY; Gamajunova VB
    J Cancer Res Clin Oncol; 2001 Feb; 127(2):135-8. PubMed ID: 11216915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity.
    Berstein LM; Imyanitov EN; Kovalevskij AJ; Maximov SJ; Vasilyev DA; Buslov KG; Sokolenko AP; Iyevleva AG; Chekmariova EV; Thijssen JH
    Cancer Lett; 2004 Apr; 207(2):191-6. PubMed ID: 15072828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A polymorphism study of the CYP19 gene in endometrial cancer patients].
    Bershteĭn LM; Imianitov EN; Suspitsyn EN; Grigor'ev MIu; Sokolov EP; Togo AV; Khanson KP; Poroshina TE; Gamaiunova VB; Vasil'ev DA; Kovalevskiĭ AIu; Volkov ON
    Vopr Onkol; 2000; 46(3):302-5. PubMed ID: 10976276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP19 (aromatase) haplotypes and endometrial cancer risk.
    Paynter RA; Hankinson SE; Colditz GA; Kraft P; Hunter DJ; De Vivo I
    Int J Cancer; 2005 Aug; 116(2):267-74. PubMed ID: 15800924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polymorphisms of the CYP17 and CYP19 genes in endometrial cancer patients.
    Szyłło K; Smolarz B; Romanowicz-Makowska H; Kulig A
    Pol J Pathol; 2006; 57(1):35-40. PubMed ID: 16739881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP17 genetic polymorphism in endometrial cancer: are only steroids involved?
    Berstein LM; Imyanitov EN; Gamajunova VB; Kovalevskij AJ; Kuligina ESh; Belogubova EV; Buslov KG; Karpova MB; Togo AV; Volkov ON; Kovalenko IG
    Cancer Lett; 2002 Jun; 180(1):47-53. PubMed ID: 11911969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal imbalance in two types of endometrial cancer and genetic polymorphism of steroidogenic enzymes.
    Berstein L; Zimarina T; Imyanitov E; Kovalevskij A; Maximov S; Pujol P; Thijssen J
    Maturitas; 2006 Jul; 54(4):352-5. PubMed ID: 16730930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The T/C polymorphism of the CYP17 gene and G/A polymorphism of the CYP19 gene in endometrial cancer.
    Szyllo K; Smolarz B; Romanowicz-Makowska H; Lewy J; Kulig B
    J Exp Clin Cancer Res; 2006 Sep; 25(3):411-6. PubMed ID: 17167982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The risk of endometrial cancer appearance and CYP19 and COMT gene polymorphism].
    Szyłło K; Smolarz B; Romanowicz-Makowska H; Przybyłowska K; Lewy J; Kulig B
    Pol Merkur Lekarski; 2007 Mar; 22(129):208-10. PubMed ID: 17682677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, and breast cancers in Novosibirsk, Russia.
    Gulyaeva LF; Mikhailova ON; PustyInyak VO; Kim IV; Gerasimov AV; Krasilnikov SE; Filipenko ML; Pechkovsky EV
    Adv Exp Med Biol; 2008; 617():359-66. PubMed ID: 18497059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.
    Tüzüner BM; Oztürk T; Kisakesen HI; Ilvan S; Zerrin C; Oztürk O; Isbir T
    In Vivo; 2010; 24(1):71-4. PubMed ID: 20133979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype.
    Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
    Eur J Endocrinol; 2008 Jun; 158(6):861-5. PubMed ID: 18505907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common polymorphism in the 5'-untranslated region of the aromatase gene influences bone mass and fracture risk.
    Zarrabeitia MT; Hernández JL; Valero C; Zarrabeitia AL; García-Unzueta M; Amado JA; González-Macías J; Riancho JA
    Eur J Endocrinol; 2004 May; 150(5):699-704. PubMed ID: 15132727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum sex steroid levels and bone mineral density with CYP17 and CYP19 gene polymorphisms in postmenopausal women in Turkey.
    Yilmaz MB; Pazarbasi A; Guzel AI; Kocaturk-Sel S; Kasap H; Kasap M; Urunsak IF; Basaran S; Alptekin D; Demirhan O
    Genet Mol Res; 2011 Sep; 10(3):1999-2008. PubMed ID: 21948762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic polymorphism of steroid 17 alpha-hydroxylase/17,20-lyase (CYP17) and hyperinsulinemia in endometrial carcinoma].
    Berstein LM; Imianitov EN; Gamaiunova VB; Kovalevskiĭ AIu; Kuligina ESh; Belogubova EV; Buslov KG; Karpova MB; Togo AV; Volkov ON; Kovalenko IG; Chernobrovkina AE
    Vopr Onkol; 2002; 48(6):673-8. PubMed ID: 12530262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk.
    Haiman CA; Hankinson SE; Spiegelman D; De Vivo I; Colditz GA; Willett WC; Speizer FE; Hunter DJ
    Int J Cancer; 2000 Jul; 87(2):204-10. PubMed ID: 10861475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are the T/C polymorphism of the CYP17 gene and the tetranucleotide repeat (TTTA) polymorphism of the CYP19 gene genetic markers for premature coronary artery disease in Caucasians?
    Letonja M; Peterlin B; Bregar D; Petrovic D
    Folia Biol (Praha); 2005; 51(3):76-81. PubMed ID: 16045239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the genetic polymorphism of the CYP19 intron 4[TTTA]n repeat with familial prostate cancer risk in a Japanese population.
    Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Ohtake N; Takei T; Nakata S; Hasumi M; Yamanaka H
    Anticancer Res; 2003; 23(6D):4941-6. PubMed ID: 14981949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.
    Lundin E; Wirgin I; Lukanova A; Afanasyeva Y; Krogh V; Axelsson T; Hemminki K; Clendenen TV; Arslan AA; Ohlson N; Sieri S; Roy N; Koenig KL; Idahl A; Berrino F; Toniolo P; Hallmans G; Försti A; Muti P; Lenner P; Shore RE; Zeleniuch-Jacquotte A
    Cancer Epidemiol; 2012 Oct; 36(5):445-52. PubMed ID: 22633539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in the CYP19A1 (aromatase) gene and endometrial cancer risk in Chinese women.
    Tao MH; Cai Q; Zhang ZF; Xu WH; Kataoka N; Wen W; Xiang YB; Zheng W; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):943-9. PubMed ID: 17507620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.